Throat Pastilles and Cough Drops Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, Japan - Size and Forecast 2024-2028

Published: Dec 2023 Pages: 162 SKU: IRTNTR40260

Throat Pastilles and Cough Drops Market 2024-2028

The global throat pastilles and cough drops market size is estimated to grow by USD 1.25 billion, at a CAGR of 3.72% between 2023 and 2028. 

Oral dosage forms differ from and have advantages over other dosage forms such as parenteral and intravenous. Oral dosage forms are economical, safe, and are the easiest route of drug administration. Owing to the advantages of oral dosage forms, throat pastilles, and cough drops are highly preferred by patients. Nowadays, several types of lozenges are available in the market, which are capable of providing several advantages and relief from symptoms of diseases. Consequently, the advantages of lozenges have increased patient propensity toward these easily available dosage forms, thereby driving the global throat pastilles and cough drops market growth during the forecast period.

Technavio has segmented the market into Type, End-user, and Geography 

  • The type segment includes hard tablet lozenges, soft tablet lozenges, and compressed tablet lozenges
  • The end-user segment includes hospitals, clinics, and others
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.

What will be the Size of the Throat Pastilles and Cough Drops Market During the Forecast Period?

To learn more about this report, Download Report Sample

Throat Pastilles and Cough Drops Market Segmentation by Type, End-user, and Geography Analysis

Type Analysis

Hard tablet lozenges

The market share growth by the hard tablet lozenges segment will be significant during the forecast period. A hard tablet lozenge is a mixture of carbohydrates and sugar in combination with a medicament in a nanocrystalline state. They can also be called solid syrups of sugars and medicament. These lozenges are made by heating sugars and other constituents together and then pouring the mixture into a mold. Several types of hard candy lozenges, such as Vicks and Strepsils, are easily available in retail stores and pharmacies at low prices. Hard candy lozenges offer multiple benefits. 

Get a glance at the market contribution of various segments Download PDF Sample

The hard tablet lozenges segment was valued at USD 2.68 billion in 2018. In addition, the availability of these lozenges in multiple colors and flavors, such as blackcurrant, cherry, honey, and lemon, has increased their acceptance and popularity among people. However, the issue in making these lozenges is that they become grainy. However, to overcome this challenge, other excipients are available and are used in the manufacturing process of hard tablet lozenges. Thus, the easy availability of these lozenges at lower prices in different flavors with multiple actions will drive the growth of the segment during the forecast period.

End-user Analysis

Hospitals

Hospitals are considered one of the major end-users were various chronic treatments of common cold and influenza. Hospitals play an important role in the consumption of lozenges for influenza and the common cold. Hospitals may also purchase lozenges directly from manufacturers and distribute them to other healthcare facilities and pharmacies. Furthermore, according to the World Health Organization, the number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Hence, such factors are expected to propel hospitals segment growth, which contributes to the global throat pastilles and cough drops market growth during the forecast period.

Clinics

Patients often prefer private clinics and specialty clinics as end-users due to low cost and easy appointments. Treatment for influenza cases is being carried out in these centers. Furthermore, physicians' clinics and private clinics are gaining prominence over hospitals, as the cost is comparatively less due to the availability of various types of clinical services, such as diagnosing, assessing, and treating influenza and the common cold. Thus, such factors are boosting the growth of the clinics segment, which, in turn, propels the growth of the market in focus during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 34% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America holds the largest market share in the global throat pastilles and cough drops market, primarily due to the increasing incidence of coughs and colds, and other diseases, including influenza and pneumonia, causing symptoms such as coughing and sore throat. Furthermore, the easy availability of throat pastilles and cough drops at very low prices and the immediate relief provided by them have also increased their demand. Therefore, the market is witnessing the launch of innovative products, which will further drive the market's growth during the forecast period.

Buy Full Report Now

Key Throat Pastilles and Cough Drops Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Andre Prost Inc: The company offers throat drops such as ginger drops, menthol eucalyptus drops, and lemon and menthol eucalyptus drops under its brand HONEES.

  • Aurobindo Pharma Ltd.
  • Boyd Pharmaceuticals
  • CVS Health Corp.
  • FISHERMANSFRIEND.COM
  • GRETHERS USA
  • iNova Pharmaceuticals
  • Johnson and Johnson
  • Lanes Health
  • Maneesh Pharmaceuticals Ltd
  • Mondelez International Inc.
  • PINE BROS LLC.
  • Prestige Consumer Healthcare Inc.
  • Prince Care Pharma Pvt Ltd
  • Procter and Gamble
  • Quantum Health
  • Reckitt Benckiser Group Plc
  • Ricola Group AG
  • STADA Arzneimittel AG
  • Walgreens Boots Alliance Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Throat Pastilles and Cough Drops Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. 

Key Throat Pastilles and Cough Drops Market Drivers

Increasing incidences of respiratory tract infections is the key factor driving market growth. The increasing incidences of respiratory tract infections such as the common cold, influenza, and pneumonia, are expected to increase the consumption of lozenges, which will drive the market growth. Common cold can cause a sore throat and runny nose, followed by coughing and sneezing. The incidence of the common cold is high in several regions globally.

Furthermore, the prevalence of pneumonia has also increased worldwide. For example, according to the CDC, approximately 900,000 Americans are affected by pneumococcal pneumonia each year. Therefore, such an increase in the prevalence of the abovementioned diseases has led to a growth in the demand for throat pastilles and cough drops for relief from the symptoms of these diseases. Thus, such factors will drive the growth of the market during the forecast period.

Significant Throat Pastilles and Cough Drops Market Trends

The growing focus of companies on enhancing distribution networks is the primary trend shaping market growth. Lozenges are majorly available over-the-counter in many countries. In developed countries, the lineup of over-the-counter drugs is expanding steadily. Manufacturers of over-the-counter drugs are taking advantage of the increasing sales through both retail channels and e-channels to grow their businesses. Nowadays, different over-the-counter drugs are available through online distribution channels and retail channels, as well as in drugstores.

Furthermore, for counter sales, lozenges can be dispensed without a prescription. In addition, the availability of lozenges in several flavors, such as ginger, honey, lemon, mint, and others, has led to greater market acceptance of these products. Therefore, making throat pastilles and cough drops available through different distribution channels is expected to boost the sales of these lozenges, thereby accelerating the market growth during the forecast period.

Major Throat Pastilles and Cough Drops Market Challenges

The inappropriate use of antibiotics to treat the common cold and influenza is a challenge that affects market growth. The wrong use of antibiotics to treat the common cold and influenza has increased. This has led to an increase in resistance to antibiotics, which may create a challenge to the market. Common cold and influenza infections are caused by several viruses. However, in some cases, a bacterial cause can be found. For cases where bacteria cause an infection, antibiotic treatment is effective. However, in a majority of cases, respiratory infections occur due to viruses, and those infections do not respond to antibiotic therapy.

In addition, physicians across the globe continue to prescribe antibiotics for the treatment of common cold and influenza infections. It was observed that the rate of antibiotic prescriptions for children is higher than that for adults. This has become a major challenge for global public health. Hence, such inappropriate use of antibiotics to treat the common cold and influenza infections may impede the growth of the global throat pastilles and cough drops market during the forecast period.

Buy Now Full Report

Key Throat Pastilles and Cough Drops Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Throat Pastilles and Cough Drops Market Customer Landscape

Segment Overview

The throat pastilles and cough drops market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

  • Type Outlook
    • Hard tablet lozenges
    • Soft tablet lozenges
    • Compressed tablet lozenges
  • End-user Outlook
    • Hospitals
    • Clinics
    • Others
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Argentina
      • Australia
      • Brazil

Throat Pastilles and Cough Drops Market Scope

Report Coverage

Details

Page number

162

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 3.72%

Market Growth 2024-2028

USD 1.25 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

3.28

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 34%

Key countries

US, Canada, Germany, UK, and Japan

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Andre Prost Inc, Aurobindo Pharma Ltd., Boyd Pharmaceuticals, CVS Health Corp., FISHERMANSFRIEND.COM, GRETHERS USA, iNova Pharmaceuticals, Johnson and Johnson, Lanes Health, Maneesh Pharmaceuticals Ltd, Mondelez International Inc., PINE BROS LLC., Prestige Consumer Healthcare Inc., Prince Care Pharma Pvt Ltd, Procter and Gamble, Quantum Health, Reckitt Benckiser Group Plc, Ricola Group AG, STADA Arzneimittel AG, and Walgreens Boots Alliance Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period. 

Customization purview

If our report has not included the data you are looking for, you can reach out to our analysts and get customized segments.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Throat Pastilles and Cough Drops Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the throat pastilles and cough drops market between 2024 and 2028
  • Precise estimation of the throat pastilles and cough drops market size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of throat pastilles and cough drops market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global throat pastilles and cough drops market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global throat pastilles and cough drops market 2018 - 2022 ($ billion)
    • 4.2 Type Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Type Segment 2018 - 2022 ($ billion)
    • 4.3 End-user Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ billion)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 Hard tablet lozenges - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Hard tablet lozenges - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 35: Data Table on Hard tablet lozenges - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Chart on Hard tablet lozenges - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Hard tablet lozenges - Year-over-year growth 2023-2028 (%)
    • 6.4 Soft tablet lozenges - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Soft tablet lozenges - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 39: Data Table on Soft tablet lozenges - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 40: Chart on Soft tablet lozenges - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Soft tablet lozenges - Year-over-year growth 2023-2028 (%)
    • 6.5 Compressed tablet lozenges - Market size and forecast 2023-2028
      • Exhibit 42: Chart on Compressed tablet lozenges - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 43: Data Table on Compressed tablet lozenges - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 44: Chart on Compressed tablet lozenges - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on Compressed tablet lozenges - Year-over-year growth 2023-2028 (%)
    • 6.6 Market opportunity by Type
      • Exhibit 46: Market opportunity by Type ($ billion)
      • Exhibit 47: Data Table on Market opportunity by Type ($ billion)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
    • 7.2 Comparison by End-user
      • Exhibit 50: Chart on Comparison by End-user
      • Exhibit 51: Data Table on Comparison by End-user
    • 7.3 Hospitals - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 53: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 54: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
    • 7.4 Clinics - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Clinics - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 57: Data Table on Clinics - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 58: Chart on Clinics - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
    • 7.5 Others - Market size and forecast 2023-2028
      • Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
      • Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 64: Market opportunity by End-user ($ billion)
      • Exhibit 65: Data Table on Market opportunity by End-user ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 Germany - Market size and forecast 2023-2028
      • Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.9 Japan - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.10 UK - Market size and forecast 2023-2028
      • Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.11 Canada - Market size and forecast 2023-2028
      • Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ billion)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 Andre Prost Inc
              • Exhibit 115: Andre Prost Inc - Overview
              • Exhibit 116: Andre Prost Inc - Product / Service
              • Exhibit 117: Andre Prost Inc - Key offerings
            • 12.4 Aurobindo Pharma Ltd.
              • Exhibit 118: Aurobindo Pharma Ltd. - Overview
              • Exhibit 119: Aurobindo Pharma Ltd. - Product / Service
              • Exhibit 120: Aurobindo Pharma Ltd. - Key offerings
            • 12.5 Boyd Pharmaceuticals
              • Exhibit 121: Boyd Pharmaceuticals - Overview
              • Exhibit 122: Boyd Pharmaceuticals - Product / Service
              • Exhibit 123: Boyd Pharmaceuticals - Key offerings
            • 12.6 CVS Health Corp.
              • Exhibit 124: CVS Health Corp. - Overview
              • Exhibit 125: CVS Health Corp. - Business segments
              • Exhibit 126: CVS Health Corp. - Key offerings
              • Exhibit 127: CVS Health Corp. - Segment focus
            • 12.7 FISHERMANSFRIEND.COM
              • Exhibit 128: FISHERMANSFRIEND.COM - Overview
              • Exhibit 129: FISHERMANSFRIEND.COM - Product / Service
              • Exhibit 130: FISHERMANSFRIEND.COM - Key offerings
            • 12.8 GRETHERS USA
              • Exhibit 131: GRETHERS USA - Overview
              • Exhibit 132: GRETHERS USA - Product / Service
              • Exhibit 133: GRETHERS USA - Key offerings
            • 12.9 iNova Pharmaceuticals
              • Exhibit 134: iNova Pharmaceuticals - Overview
              • Exhibit 135: iNova Pharmaceuticals - Product / Service
              • Exhibit 136: iNova Pharmaceuticals - Key offerings
            • 12.10 Johnson and Johnson
              • Exhibit 137: Johnson and Johnson - Overview
              • Exhibit 138: Johnson and Johnson - Business segments
              • Exhibit 139: Johnson and Johnson - Key news
              • Exhibit 140: Johnson and Johnson - Key offerings
              • Exhibit 141: Johnson and Johnson - Segment focus
            • 12.11 Lanes Health
              • Exhibit 142: Lanes Health - Overview
              • Exhibit 143: Lanes Health - Product / Service
              • Exhibit 144: Lanes Health - Key offerings
            • 12.12 Mondelez International Inc.
              • Exhibit 145: Mondelez International Inc. - Overview
              • Exhibit 146: Mondelez International Inc. - Business segments
              • Exhibit 147: Mondelez International Inc. - Key news
              • Exhibit 148: Mondelez International Inc. - Key offerings
              • Exhibit 149: Mondelez International Inc. - Segment focus
            • 12.13 PINE BROS LLC.
              • Exhibit 150: PINE BROS LLC. - Overview
              • Exhibit 151: PINE BROS LLC. - Product / Service
              • Exhibit 152: PINE BROS LLC. - Key offerings
            • 12.14 Prestige Consumer Healthcare Inc.
              • Exhibit 153: Prestige Consumer Healthcare Inc. - Overview
              • Exhibit 154: Prestige Consumer Healthcare Inc. - Business segments
              • Exhibit 155: Prestige Consumer Healthcare Inc. - Key offerings
              • Exhibit 156: Prestige Consumer Healthcare Inc. - Segment focus
            • 12.15 Procter and Gamble
              • Exhibit 157: Procter and Gamble - Overview
              • Exhibit 158: Procter and Gamble - Business segments
              • Exhibit 159: Procter and Gamble - Key offerings
              • Exhibit 160: Procter and Gamble - Segment focus
            • 12.16 Reckitt Benckiser Group Plc
              • Exhibit 161: Reckitt Benckiser Group Plc - Overview
              • Exhibit 162: Reckitt Benckiser Group Plc - Business segments
              • Exhibit 163: Reckitt Benckiser Group Plc - Key offerings
              • Exhibit 164: Reckitt Benckiser Group Plc - Segment focus
            • 12.17 Ricola Group AG
              • Exhibit 165: Ricola Group AG - Overview
              • Exhibit 166: Ricola Group AG - Product / Service
              • Exhibit 167: Ricola Group AG - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 168: Inclusions checklist
                • Exhibit 169: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 170: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 171: Research methodology
                • Exhibit 172: Validation techniques employed for market sizing
                • Exhibit 173: Information sources
              • 13.5 List of abbreviations
                • Exhibit 174: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              throat pastilles and cough drops market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis